This bill aims to expand research and education on endometrial cancer, specifically addressing significant disparities in incidence and mortality rates, particularly among African-American women. It acknowledges the increasing prevalence of aggressive endometrial cancer subtypes and the unknown causes of racial disparities, which may be linked to delays in care and socioeconomic factors. The legislation directs the National Institutes of Health to intensify and coordinate research, communicate findings on disparities to medical professionals, and ensure appropriate representation of African-American women in clinical trials. Concurrently, the Centers for Disease Control and Prevention is tasked with developing and disseminating public informational materials on endometrial cancer, covering risk factors, incidence, and treatments, with a specific focus on African-American women. For these efforts, the bill authorizes $1,000,000 annually for NIH for fiscal years 2026-2028, and "such sums as may be necessary" for CDC for the same period.